Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Yu Fan

Q2 2023 · 13F-HR

Yu Fanholdings as filed

Filed 2023-08-14 · accession 0000950123-23-008115

$1.3M
Reported value
5
Positions
2023-06-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
835431107SONENDO INC$745,20558.5%547,945CommonSOLE
14843C105CSTLCASTLE BIOSCIENCES INC$282,52222.2%20,592CommonSOLE
03759B102APEXIGEN INC$172,67513.5%401,757CommonSOLE
00773J103AEGLEA BIOTHERAPEUTICS INC$50,4763.96%112,044CommonSOLE
G72245106PRENETICS GLOBAL LTD$24,0001.88%25,000CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.